Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA, a leading biopharmaceutical company headquartered in Belgium, is renowned for its innovative approach to women's health. Founded in 1999, Mithra has established a strong presence in Europe and beyond, focusing on the development of contraceptive solutions and hormone therapies. The company’s flagship products, including the unique contraceptive pill Estelle and the innovative hormone replacement therapy, are designed to meet the specific needs of women, setting Mithra apart in a competitive market. With a commitment to research and development, Mithra has achieved significant milestones, positioning itself as a key player in the women's health sector. Recognised for its dedication to quality and innovation, Mithra Pharmaceuticals continues to expand its portfolio, striving to improve the lives of women globally through effective and safe healthcare solutions.
DitchCarbon Score
How does Mithra Pharmaceuticals SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mithra Pharmaceuticals SA's score of 28 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mithra Pharmaceuticals SA's reported carbon emissions
Mithra Pharmaceuticals SA, headquartered in Belgium, currently does not have available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any climate commitments or pledges, indicating a lack of formalised strategies in addressing carbon emissions at this time. As there are no emissions figures or reduction initiatives reported, it is unclear how Mithra Pharmaceuticals SA is approaching climate change and sustainability within its operations. The absence of data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction, often setting science-based targets to align with global climate goals. However, without specific commitments or data from Mithra Pharmaceuticals SA, it is difficult to assess their position relative to industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mithra Pharmaceuticals SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
